Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection
Alpha-particle radiotherapy has gained considerable attention owing to its potent anti-cancer effect. <sup>211</sup>At, with a relatively short half-life of 7.2 h, emits an alpha particle within a few cell diameters with high kinetic energy, which damages cancer cells with high biologica...
Saved in:
Main Authors: | Xuhao Huang (Author), Kazuko Kaneda-Nakashima (Author), Yuichiro Kadonaga (Author), Kazuya Kabayama (Author), Atsushi Shimoyama (Author), Kazuhiro Ooe (Author), Hiroki Kato (Author), Atsushi Toyoshima (Author), Atsushi Shinohara (Author), Hiromitsu Haba (Author), Yang Wang (Author), Koichi Fukase (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial
by: Sadahiro Naka, et al.
Published: (2024) -
The Different Strategies for the Radiolabeling of [<sup>211</sup>At]-Astatinated Radiopharmaceuticals
by: Jie Gao, et al.
Published: (2024) -
Astatine-211 radiolabelling chemistry: from basics to advanced biological applications
by: Maarten Vanermen, et al.
Published: (2024) -
Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211
by: Chiara Timperanza, et al.
Published: (2023) -
In vitro and in vivo evaluation of a tetrazine-conjugated poly-L-lysine effector molecule labeled with astatine-211
by: Chiara Timperanza, et al.
Published: (2024)